期刊文献+

黄连解毒汤主要有效成分对人CYP450酶的体外抑制作用研究 被引量:8

Rinhibition of Human CYP Enzymes in vitro by Active Component from Huanglian Jiedu Decoction
原文传递
导出
摘要 目的:体外评价黄连解毒汤主要有效成分对人肝细胞色素P450(CYP1A2,CYP2A6,CYP2B6,CYP2C9,CYP2D6,CYP3A4)活性的影响。方法:利用液质联用仪(LC-MS-MS)建立同时测定6种探针药物的分析方法,选择合适的孵育体系、孵育时间、蛋白浓度建立Cocktail模型,并通过工具药进行验证。利用Cocktail模型筛选黄芩苷、汉黄芩苷、黄芩素、汉黄芩素、小檗碱、药根碱、黄连碱、表小檗碱、巴马汀、兰花碱、栀子苷对6种酶活性抑制的体外评价。结果:黄芩素、汉黄芩素及黄芩苷对CYP1A2的IC50分别为37.7,46.3,49.9μmol·L-1,小檗碱、药根碱、黄连碱、表小檗碱对CYP2D6抑制作用的IC50分别为39.7,46.5,7.3,11.5μmol·L-1。结论:黄连解毒汤中黄芩及黄连的主要有效成分对细胞色素P450酶有不同程度的抑制,在临床联合用药时要注意代谢层面的相互作用,减少不良反应的发生。 Objective: To study the inhibition of the human CYP enzymes in vitro by active components from Huanglian Jiedu decoction. Method: A LC-MS-MS method was used to simultaneously determine six probe metabolites from human liver microsome to optimize the incubation conditions such as incubation time, microsomal concentration, and probe concentration. A specific P4_50 inhibitor was as positive control. The inhibitory potential of baicalin, wogonoside, baicalein, wogonin, berberine, jateorhizine, coptisine, epiberberine, palmatine, magnoflorine, jasminoidin on six CYP enzymes was investigated. Result: The IC_50 of baicalein, wogonin, wogonoside to CYP1A2 was 37.7, 46.3, 49.9 μmol · L-1. The IC_50 of berberine, jateorhizine, coptisine, epiberberine to CYP2D6 was 39.7, 46.5, 7.3, 11.5 μmol · L-1. Conclusion: The active component of Scutellaria and coptis chinensis in the Huanglian Jiedu decoction show some inhibitory on some CYP enzymes.
出处 《中国实验方剂学杂志》 CAS 北大核心 2014年第12期115-118,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 中国中医科学院自主选题项目(2010zz003)
关键词 黄连解毒汤 细胞色素P450 液质联用仪 Huanglian Jiedu decoction Cytochrome P450 LC-MS-MS
  • 相关文献

参考文献19

  • 1乔晓莉,赵倩,肖学凤.黄连解毒汤研究概况[J].天津药学,2008,20(1):65-67. 被引量:7
  • 2张丽美,李贵海.黄连解毒汤的药理及临床研究进展[J].时珍国医国药,2007,18(7):1635-1637. 被引量:47
  • 3蔚青,周苏宁.黄连解毒汤防治2型糖尿病研究进展[J].辽宁中医药大学学报,2010,12(3):98-99. 被引量:10
  • 4宋建芳,边宝林,王宏洁.黄连解毒汤治疗老年性痴呆药理研究进展[J].中国中医药信息杂志,2010,17(5):110-112. 被引量:9
  • 5Ekins S, Wrighton S A. Application of in silico approaches to predicting drug-drug interactions. [ J ] Pharmacol Toxicol Methods ,2011,45 ( 3 ) :65.
  • 6Caroline A L, Sue H K, Thomas A K, et al. CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3 A4 and human NADPH cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4 [J]. Arch Biochem Biophys, 1995, 319( 1 ) :157.
  • 7Arthur G R, William M A. Energetics of heterotropic cooperativity between-naphthoflavone and testosterone binding to CYP3A4[J]. Arch Bioehem Biophys, 2007, 463 ( 1 ) : 89.
  • 8Hiroyuki Y, Kazuko D. Evidence for singlet oxygen in volvement in rat and human eytochrome P450 dependent substrate oxidations [ J ]. Drug Metab Pharm Aeokin,2002,17 (5) :416.
  • 9Zhou S, Gao Y, Jiang W, et al. Interactions of herbs with cytoehrome P450 [ J]. Drug Metab Rev, 2003, 35:35.
  • 10Samuel A Testino, Jr Gabor Patonay. High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography Jtandem mass spectrometry [ J ]. J Pharm Bio Analy, 2003,30 : 1459.

二级参考文献159

共引文献123

同被引文献100

引证文献8

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部